Pneumocystis jirovecii pneumonia: Difference between revisions

Line 17: Line 17:
== Differential Diagnosis==
== Differential Diagnosis==
{{SOB DDX}}
{{SOB DDX}}
{{HIV associated conditions}}


== Diagnosis ==
== Diagnosis ==

Revision as of 10:36, 1 August 2015

Background

  • Pneumocystis (carinii) jiroveci
  • Most common opportunistic infection in AIDS pts
  • Most common identifiable cause of death
  • Risk factors:
    • CD4 < 200
    • Immunosuppressive medications
    • Cancer
    • Primary immunodeficiencies
    • Severe malnutrition

Clinical Features

  • Fever (62%)
  • Dry cough
  • Shortness of breath (progressive from exertion only to at rest)

Differential Diagnosis

Acute dyspnea

Emergent

Non-Emergent

HIV associated conditions

Diagnosis

Work-Up

  • CBC
  • Chemistry
  • LDH
  • ABG
  • CD4 count
  • CXR - bat wing appearance (bilat interstitial infiltrates)
  • A-a gradient
    • P(A-a)O2 = 145 – PaCO2 – PaO2 (normal is <10 in young, healthy pts)

Evaluation

  • Imaging
    • CXR
      • Normal in 25% of cases
      • Diffuse, interstitial infiltrates
    • CT Chest
      • Sn 100%, Sp 89%
      • May see ground glass infiltrative pattern
  • Labs
    • LDH
      • Low Sn, Sp
    • ABG
      • Hypoxemia, increased A-a gradient

Treatment

Antibiotics

Mild Disease

  • TMP/SMX 2 DS tablets PO q8hrs daily OR
    • High incidence of allergy in HIV
  • Dapsone 100mg PO once daily + TMP 5mg/kg PO q8hrs OR
    • caution: dapsone can cause methemoglobinemia
  • Atavaquone 750mg PO q12hrs OR
  • Primaquine 30mg PO q24hrs + Clindamycin 450mg PO q8hrs

Severe Disease

  • TMP/SMX 5mg/kg IV q8hrs daily x 21 days OR
  • Pentamidine 4mg/kg IV daily infused over 60 minutes OR
    • Watch for side effects of hypoglycemia and hypotension
  • Primaquine 30mg PO once daily + Clindamycin 900mg IV q8hrs daily

Prophylaxis

  • TMP/SMX 1 double strength tablet daily, but one single strength tablet daily or one double-strength three times weekly is acceptable.[2]

Disposition

  • Symptoms usually worsen 2-3d after start of treatment
  • Patients with disease severe enough to warrant IV therapy or steroids should be admitted

References

  1. Gutteridge, David L MD, MPH, Egan, Daniel J. MD. The HIV-Infected Adult Patient in The Emergency Department: The Changing Landscape of the Disease. Emergency Medicine Practice: An Evidence-Based Approach to Emergency Medicine. Vol 18, Num 2. Feb 2016.
  2. CDC Guidelines for Prophylaxis Against Pneumocystis carinii Pneumonia for Children Infected with Human Immunodeficiency Virus http://www.cdc.gov/mmwr/preview/mmwrhtml/00001957.htm